These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2666052)

  • 1. Ras oncogene and the acquisition of metastasizing properties by rectal adenocarcinoma.
    Michelassi F; Erroi F; Roncella M; Block GE
    Dis Colon Rectum; 1989 Aug; 32(8):665-8. PubMed ID: 2666052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras oncogene expression as a prognostic indicator in rectal adenocarcinoma.
    Michelassi F; Vannucci LE; Montag A; Chappell R; Rodgers J; Block GE
    J Surg Res; 1988 Jul; 45(1):15-20. PubMed ID: 3392989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between ras oncogene expression and clinical and pathological features of colonic carcinoma.
    Michelassi F; Grad G; Erroi F; Roncella M; Romagnoli J; Handcock M
    Hepatogastroenterology; 1990 Oct; 37(5):513-6. PubMed ID: 2253930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ras oncogene p21 protein in esophageal squamous cell carcinoma.
    Ruol A; Stephens JK; Michelassi F; Segalin A; Chiarelli S; Peracchia A; Skinner DB; Little AG
    J Surg Oncol; 1990 Jul; 44(3):142-5. PubMed ID: 2196399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms.
    Williams AR; Piris J; Spandidos DA; Wyllie AH
    Br J Cancer; 1985 Nov; 52(5):687-93. PubMed ID: 3904801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ras p21 expression in the progression of breast cancer.
    Fromowitz FB; Viola MV; Chao S; Oravez S; Mishriki Y; Finkel G; Grimson R; Lundy J
    Hum Pathol; 1987 Dec; 18(12):1268-75. PubMed ID: 3315956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9.
    Allen DC; Foster H; Orchin JC; Biggart JD
    J Clin Pathol; 1987 Feb; 40(2):157-62. PubMed ID: 3546394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ras oncogene p21 protein in relation to regional spread of human breast carcinomas.
    Czerniak B; Chen R; Tuziak T; Markiewski M; Kram A; Gorczyca W; Deitch D; Herz F; Koss LG
    Cancer; 1989 May; 63(10):2008-13. PubMed ID: 2467732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
    Yaginuma Y; Yamashita K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ras p21 oncoprotein expression in human colonic neoplasia--an immunohistochemical study with monoclonal antibody RAP-5.
    Lanza G
    Histopathology; 1988 Jun; 12(6):595-609. PubMed ID: 3047043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma.
    Sun XF; Wingren S; Carstensen JM; Stål O; Hatschek T; Boeryd B; Nordenskjöld B; Zhang H
    Eur J Cancer; 1991; 27(12):1646-9. PubMed ID: 1782077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
    Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
    Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
    Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
    J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras oncogene p21 levels parallel malignant potential of different human colonic benign conditions.
    Michelassi F; Leuthner S; Lubienski M; Bostwick D; Rodgers J; Handcock M; Block GE
    Arch Surg; 1987 Dec; 122(12):1414-6. PubMed ID: 3318757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes B patients.
    Thebo JS; Senagore AJ; Reinhold DS; Stapleton SR
    Dis Colon Rectum; 2000 Feb; 43(2):155-9; discussion 159-62. PubMed ID: 10696887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of ras p21 overexpression for patients with an advanced colorectal cancer.
    Miyahara M; Saito T; Kaketani K; Sato K; Kuwahara A; Shimoda K; Kobayashi M
    Dis Colon Rectum; 1991 Dec; 34(12):1097-102. PubMed ID: 1959459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between metastasis of human rectal carcinoma and the absence of stromal fibronectin.
    Niemczuk P; Perkins RM; Talbot IC; Critchley DR
    Br J Cancer; 1982 Apr; 45(4):500-5. PubMed ID: 7041942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras p21 expression in relation to histopathological variables and prognosis in colorectal adenocarcinoma.
    Sun XF; Hatschek T; Wingren S; Stål O; Carstensen JM; Zhang H; Boeryd B; Sjödahl R; Nordenskjöld B
    Acta Oncol; 1991; 30(8):933-9. PubMed ID: 1777245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen Activation System in Rectal Adenocarcinoma.
    Razik E; Kobierzycki C; Grzegrzolka J; Podhorska-Okolow M; Drag-Zalesinska M; Zabel M; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6009-15. PubMed ID: 26504024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study.
    Kune GA; Kune S; Field B; White R; Brough W; Schellenberger R; Watson LF
    Dis Colon Rectum; 1990 Nov; 33(11):938-46. PubMed ID: 2226081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.